ATE345119T1 - Kaliumtauratbikarbonat und ascorbat komplexe - Google Patents

Kaliumtauratbikarbonat und ascorbat komplexe

Info

Publication number
ATE345119T1
ATE345119T1 AT04715183T AT04715183T ATE345119T1 AT E345119 T1 ATE345119 T1 AT E345119T1 AT 04715183 T AT04715183 T AT 04715183T AT 04715183 T AT04715183 T AT 04715183T AT E345119 T1 ATE345119 T1 AT E345119T1
Authority
AT
Austria
Prior art keywords
potassium
bicarbonate
ascorbate
complexes
taurate
Prior art date
Application number
AT04715183T
Other languages
English (en)
Inventor
Herb Boynton
Original Assignee
Nutrition Corp Of America Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrition Corp Of America Ltd filed Critical Nutrition Corp Of America Ltd
Application granted granted Critical
Publication of ATE345119T1 publication Critical patent/ATE345119T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/40Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • A23L33/165Complexes or chelates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Birds (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT04715183T 2003-03-04 2004-02-26 Kaliumtauratbikarbonat und ascorbat komplexe ATE345119T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45250703P 2003-03-04 2003-03-04
US10/756,205 US6881750B2 (en) 2003-03-04 2004-01-13 Potassium taurate bicarbonate and ascorbate

Publications (1)

Publication Number Publication Date
ATE345119T1 true ATE345119T1 (de) 2006-12-15

Family

ID=32930720

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04715183T ATE345119T1 (de) 2003-03-04 2004-02-26 Kaliumtauratbikarbonat und ascorbat komplexe

Country Status (8)

Country Link
US (1) US6881750B2 (de)
EP (1) EP1599198B1 (de)
JP (1) JP2006519859A (de)
AT (1) ATE345119T1 (de)
AU (1) AU2004218421A1 (de)
CA (1) CA2517537A1 (de)
DE (1) DE602004003225D1 (de)
WO (1) WO2004078170A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10251909B2 (en) * 2007-02-09 2019-04-09 Board Of Regents, The University Of Texas System Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension
US20090005320A1 (en) * 2008-09-02 2009-01-01 Bruce Kneller Compositions comprising amino acid bicarbonate and methods of use thereof
CN105030748A (zh) * 2015-08-05 2015-11-11 邵志辉 牛磺酸钾镁组合物及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2384751A1 (fr) * 1977-03-23 1978-10-20 Francaise Coop Pharma Nouveaux derives de la taurine a activite neuro-musculaire renforcee
FR2605854B1 (fr) 1986-10-30 1990-07-06 Futur Quotidien Sa Complement dietetique a des fins energetiques
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
US5723496A (en) 1991-03-05 1998-03-03 The Regents Of University Of California Method for prevention and treatment of harmful effects of intracellular acidosis
US5434276A (en) * 1993-12-27 1995-07-18 Finetex, Inc. Process for making N-acyl taurides
EP0778021A4 (de) 1994-09-14 1998-06-03 Taisho Pharmaceutical Co Ltd Augentropfen zur behandlung von corneaschäden
US5776498A (en) * 1995-11-06 1998-07-07 Nutrition 21 Magnesium taurate as an adjuvant to rapid thrombolytic therapy
US5582839A (en) * 1995-04-18 1996-12-10 Nutrition 21 Magnesium taurate and other mineral taurates
US6099869A (en) * 1995-04-18 2000-08-08 Nutrition 21 Calcium taurate and antihypertensive drug for hypertension
US5651813A (en) * 1995-11-30 1997-07-29 Eastman Kodak Company Preparation of ink jet inks with sodium N-methyl-N-oleoyl taurate
US5773373A (en) * 1996-06-18 1998-06-30 Reef Industries, Inc. Reinforced laminate with elastomeric tie layer
US6200950B1 (en) 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
US5985017A (en) 1998-10-27 1999-11-16 Eastman Kodak Company Potassium N-methyl-N-oleoyl taurate as a dispersant in pigmented ink jet inks
DE69910746T2 (de) * 1999-06-26 2004-06-17 B. Braun Melsungen Ag Wässrige Lösung für parenterale Nahrung

Also Published As

Publication number Publication date
WO2004078170A1 (en) 2004-09-16
EP1599198A1 (de) 2005-11-30
DE602004003225D1 (de) 2006-12-28
EP1599198B1 (de) 2006-11-15
AU2004218421A1 (en) 2004-09-16
US20040176442A1 (en) 2004-09-09
US6881750B2 (en) 2005-04-19
CA2517537A1 (en) 2004-09-16
JP2006519859A (ja) 2006-08-31

Similar Documents

Publication Publication Date Title
MY143795A (en) Tetrahydropyridoindole derivatives
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
HRP20121072T1 (hr) Postupci za davanje tetrahidrobiopterina, povezani pripravci i postupci mjerenja
EP2074985A3 (de) Aktivator, der ein Biotensid als Wirkstoff enthält, Mannosylerythritol-Lipid und zugehöriges Produktionsverfahren
WO2007067582A3 (en) Process for manufacturing chewable dosage forms for drug delivery and products thereof
NO20064186L (no) Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
IL163894A (en) 2-hydroxy-3-heteroarylindole derivatives, pharmaceutical compositions comprising them and their uses in the preparation of medicaments
EP2219626A4 (de) Verfahren zur herstellung von kaubaren dosierformen zur arzneiabgabe und produkte dafür
NZ599361A (en) A solid pharmaceutical dosage formulation
MY144897A (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
ES2187300A1 (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
MY148723A (en) Use of pinolenic acid for the treatment of obesity
WO2008093793A1 (ja) 口腔内乾燥症の緩和または予防剤
DK1755578T3 (da) Tygbar, sugbar og slugbar tablet indeholdende en calcium-holdig forbindelse som aktivt stof
EP2241196A3 (de) Oligosaccharide und Zysteine enthaltendes Nahrungsergänzungsmittel zur behandlung von hiv
GB2443793B (en) Product, method of manufacture and use
TW200633696A (en) Sesamin/episesamin compositions
RU2006131758A (ru) Композиция для предупреждения простуды
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
ES2195902T3 (es) Composicion que comprende esfingomielinasa alcalina para uso como preparacion dietetica, complemento alimenticio o producto farmaceutico.
NO20092763L (no) Isosorbid mononitrat derivater for behandling av tarmlidelser
DE602004016301D1 (de) Tablette mit wasserabsorbierender aminosäure
MY153109A (en) A solid pharmaceutical formulation
RU2484824C2 (ru) Мультивитаминная/минеральная композиция для борьбы с эффектами экологического стресса, повышения иммунитета и повышения активности, направленная на недостаточности витаминов и минералов без негативных побочных эффектов мегадозовой пищевой добавки
ATE345119T1 (de) Kaliumtauratbikarbonat und ascorbat komplexe

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties